References
- DasSRaizerJJMuroKImmunotherapeutic treatment strategies for primary brain tumorsCurr Treat Options Oncol2200891324018363109
- LuptrawanALiuGYuJSDendritic cell immunotherapy for malignant gliomasRev Recent Clin Trials1200831102118474011
- McBrideWHCombining radiation therapy with immunotherapy for treatment of brain tumorsLiauLMBeckerDPCloughesyTFBignerDDBrain Tumor Immunotherapy1st edNew JerseyHumana Press2001345362
- MitchellDAFecciPESampsonJHImmunotherapy of malignant brain tumorsImmunol Rev420082227010018363995
- YangIHanSJKaurGCraneCParsaATThe role of microglia in central nervous system immunity and glioma immunologyJ Clin Neurosci1201017161019926287
- RobinsonMJSanchoDSlackECLeibundGut-LandmannSReis e SousaCMyeloid C-type lectins in innate immunityNat Immunol1220067121258126517110942
- EgginkLLHooberJKA biologically active peptide mimetic of N-acetylgalactosamine/galactoseBMC Res Notes200922319284521
- EgginkLLSalasMHansonCVHooberJKPeptide sugar mimetics prevent HIV type 1 replication in peripheral blood mononuclear cells in the presence of HIV-positive antiserumAIDS Res Hum Retroviruses2201026214916020156098
- Garcia-VallejoJJvan KooykYEndogenous ligands for C-type lectin receptors: the true regulators of immune homeostasisImmunol Rev720092301223719594627
- GeijtenbeekTBGringhuisSISignalling through C-type lectin receptors: shaping immune responsesNat Rev Immunol720099746547919521399
- HigashiNFujiokaKDenda-NagaiKThe macrophage C-type lectin specific for galactose/N-acetylgalactosamine is an endocytic receptor expressed on monocyte-derived immature dendritic cellsJ Biol Chem67200227723206862069311919201
- DagaAOrengoAMGangemiRMGlioma immunotherapy by IL-21 gene-modified cells or by recombinant IL-21 involves antibody responsesInt J Cancer1015200712181756176317582604
- SkakKKraghMHausmanDSmythMJSivakumarPVInterleukin 21: combination strategies for cancer therapyNat Rev Drug Discov320087323124018259184
- ElsaesserHSauerKBrooksDGIL-21 is required to control chronic viral infectionScience619200932459341569157219423777
- AschASLeungLLShapiroJNachmanRLHuman brain glial cells synthesize thrombospondinProc Natl Acad Sci U S A51986839290429082939460
- BadieBSchartnerJMPaulJBartleyBAVorpahlJPrestonJKDexamethasone-induced abolition of the inflammatory response in an experimental glioma model: a flow cytometry studyJ Neurosurg10200093463463911014542
- ParneyIFWaldronJSParsaATFlow cytometry and in vitro analysis of human glioma-associated macrophages. Laboratory investigationJ Neurosurg32009110357258219199469
- RandolphGJJakubzickCQuCAntigen presentation by monocytes and monocyte-derived cellsCurr Opin Immunol22008201526018160272
- GraberDJHickeyWFHarrisBTProgressive changes in microglia and macrophages in spinal cord and peripheral nerve in the transgenic rat model of amyotrophic lateral sclerosisJ Neuroinflammation20107820109233
- Le CabecVCarrenoSMoisandABordierCMaridonneau-PariniIComplement receptor 3 (CD11b/CD18) mediates type I and type II phagocytosis during nonopsonic and opsonic phagocytosis, respectivelyJ Immunol815200216942003200912165526
- MitrasinovicOMPerezGVZhaoFLeeYLPoonCMurphyGMJrOverexpression of macrophage colony-stimulating factor receptor on microglial cells induces an inflammatory responseJ Biol Chem810200127632301423014911387343
- MitrasinovicOMRobinsonCCTenenDGLeeYLPoonCMurphyGMJrBiolistic expression of the macrophage colony stimulating factor receptor in organotypic cultures induces an inflammatory responseJ Neurosci Res81200477342042915248298
- RoyAFungYKLiuXPahanKUp-regulation of microglial CD11b expression by nitric oxideJ Biol Chem526200628121149711498016551637
- ButovskyOKoronyo-HamaouiMKunisGGlatiramer acetate fights against Alzheimer’s disease by inducing dendritic-like microglia expressing insulin-like growth factor 1Proc Natl Acad Sci U S A81200610331117841178916864778
- SantambrogioLBelyanskayaSLFischerFRDevelopmental plasticity of CNS microgliaProc Natl Acad Sci U S A522200198116295630011371643
- KennedyBCMaierLMD’AmicoRDynamics of central and peripheral immunomodulation in a murine glioma modelBMC Immunol2009101119226468
- KostianovskyAMMaierLMAndersonRCBruceJNAndersonDEAstrocytic regulation of human monocytic/microglial activationJ Immunol1015200818185425543218832699
- WeiJWuAKongLYHypoxia potentiates glioma-mediated immunosuppressionPLoS One201161e1619521283755
- ZhaiHHeppnerFLTsirkaSEMicroglia/macrophages promote glioma progressionGlia3201159347248521264953
- KomoharaYOhnishiKKuratsuJTakeyaMPossible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomasJ Pathol20082161152418553315
- FischerHGReichmannGBrain dendritic cells and macrophages/microglia in central nervous system inflammationJ Immunol215200116642717272611160337
- FujiwaraNKobayashiKMacrophages in inflammationCurr Drug Targets Inflamm Allergy620054328128616101534
- KanalyCWDingDHeimbergerABSampsonJHClinical applications of a peptide-based vaccine for glioblastomaNeurosurg Clin N Am120102119510919944970
- de VleeschouwerSRappMSorgRVDendritic cell vaccination in patients with malignant gliomas: current status and future directionsNeurosurgery11200659598899917143233
- AkasakiYKikuchiTIrieMCotransfection of Poly(I: C) and siRNA of IL-10 into fusions of dendritic and glioma cells enhances antitumor T helper type 1 induction in patients with gliomaJ Immunother3201134212112821304408